Jin Medical International (ZJYL) Liabilities and Shareholders Equity (2022 - 2025)

Jin Medical International's Liabilities and Shareholders Equity history runs 4 years deep, the most recent figure standing at $53.4 million for Q3 2025.

• In Q3 2025, Liabilities and Shareholders Equity rose 16.52% year-over-year to $53.4 million; the TTM figure through Sep 2025 stood at $99.2 million (up 26.0% YoY), while the FY2025 annual figure was $53.4 million, up 16.52% from the prior year.
• Liabilities and Shareholders Equity came in at $53.4 million for Q3 2025 at Jin Medical International, up from $45.8 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $53.4 million in Q3 2025 to a low of $20.9 million in Q3 2022.
• A 4-year average of $38.3 million and a median of $39.4 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity jumped 57.14% in 2023 and grew 16.52% in 2025, its largest moves.
• Jin Medical International's Liabilities and Shareholders Equity stood at $20.9 million in 2022, then surged by 57.14% to $32.9 million in 2023, then surged by 39.2% to $45.8 million in 2024, then increased by 16.52% to $53.4 million in 2025.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $53.4 million, $45.8 million, and $32.9 million for Q3 2025, Q3 2024, and Q3 2023 respectively.

Peer Comparison